Home
August 2008 September 2008 October 2008
Su Mo Tu We Th Fr Sa
Week 36 1 2 3 4 5 6
Week 37 7 8 9 10 11 12 13
Week 38 14 15 16 17 18 19 20
Week 39 21 22 23 24 25 26 27
Week 40 28 29 30

Prostate High-Dose-Rate Brachytherapy as Salvage Treatment of Local Failure after Previous External or Permanent Seed Irradiation for Prostate Cancer - Abstract Show Comments PDF Print E-mail
  
Wednesday, 02 July 2008

Radiation Oncology, Central Indiana Cancer Centers, Indianapolis, IN; US Oncology, Houston, TX.

To report our results in using high-dose-rate (HDR) brachytherapy for salvage of local-only failure, after either external beam radiation or permanent seed implant.

The data from 7 patients treated with salvage HDR brachytherapy at our institution was retrospectively reviewed. Information was gathered from chart review and prostate HDR specific questionnaires completed at followup visits.

All 7 patients had local-only failure defined by transrectal biopsy. Median followup is 58 months (range, 27-63), with a 71% disease-free survival rate; median survival has not yet been reached. Two patients died of metastatic disease. There have been no further local failures. There has been no Grade 3 or higher rectal injuries. Five patients (71%) developed symptomatic urethral strictures; two previous seed failures developed incontinence with urethral necrosis, salvaged by placement of artificial sphincter or continent catheter channel. These results compare favorably to reported results with salvage permanent seed brachytherapy, prostatectomy, and cryotherapy.

HDR brachytherapy as salvage of local-only failure after previous radiation has limited data reported to date. The disease control rates and complications of treatment compare very favorably with those reported using other modalities. This approach merits further investigation.

Written by
Tharp M, Hardacre M, Bennett R, Jones WT, Stuhldreher D, Vaught J.

Reference
Brachytherapy. 2008 Jun 23. Epub ahead of print.
doi:10.1016/j.brachy.2008.03.003

PubMed Abstract
PMID:18579446

UroToday.com Prostate Cancer Section

 

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 0
PoorBest


 
< Prev   Next >